MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET
Xi Chen(Qiqihar University), Jianying Zhou(First Affiliated Hospital Zhejiang University)
Cited by 18
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
A Chemical-Genetic Approach to Studying Neurotrophin Signaling
|Neuron|2005|249
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183
Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling
|Analytical and Bioanalytical Chemistry|2018|165